Kangstem Biotech Co. Ltd (217730) - Total Liabilities

Latest as of June 2026: ₩11.86 Billion KRW ≈ $8.04 Million USD

Based on the latest financial reports, Kangstem Biotech Co. Ltd (217730) has total liabilities worth ₩11.86 Billion KRW (≈ $8.04 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 217730 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Kangstem Biotech Co. Ltd - Total Liabilities Trend (2015–2025)

This chart illustrates how Kangstem Biotech Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Kangstem Biotech Co. Ltd (217730) total assets.

Kangstem Biotech Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Kangstem Biotech Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Wam Alternative Assets Ltd AU:WMA	Australia	AU$8.22 Million
NIIT Limited NSE:NIITLTD	India	Rs-10.70 Billion
Greystone Housing Impact Investors LP NYSE:GHI	USA	$1.12 Trillion
Sungshin Cemen KO:004980	Korea	₩749.88 Billion
Diamond Building Products Public Company Limited BK:DRT	Thailand	฿1.67 Billion
AirBoss of America Corp. TO:BOS	Canada	CA$171.05 Million
UNIBEP S.A. WAR:UNI	Poland	zł1.64 Billion
Davicom Semiconductor Inc TW:3094	Taiwan	NT$104.36 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Kangstem Biotech Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 217730 net asset quality score to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.96	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.21	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.17	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kangstem Biotech Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kangstem Biotech Co. Ltd (2015–2025)

The table below shows the annual total liabilities of Kangstem Biotech Co. Ltd from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩12.43 Billion ≈ $8.43 Million	-2.90%
2024-12-31	₩12.80 Billion ≈ $8.68 Million	-65.15%
2023-12-31	₩36.74 Billion ≈ $24.90 Million	+10.21%
2022-12-31	₩33.33 Billion ≈ $22.59 Million	-4.97%
2021-12-31	₩35.07 Billion ≈ $23.77 Million	+13.56%
2020-12-31	₩30.89 Billion ≈ $20.93 Million	-28.04%
2019-12-31	₩42.92 Billion ≈ $29.09 Million	+68.30%
2018-12-31	₩25.50 Billion ≈ $17.28 Million	+13.65%
2017-12-31	₩22.44 Billion ≈ $15.21 Million	-8.27%
2016-12-31	₩24.46 Billion ≈ $16.58 Million	+553.16%
2015-12-31	₩3.75 Billion ≈ $2.54 Million	--

About Kangstem Biotech Co. Ltd

KQ:217730 Korea Biotechnology

Market Cap

$135.45 Million

₩199.87 Billion KRW

Market Cap Rank

#18131 Global

#793 in Korea

Share Price

₩2125.00

Change (1 day)

-0.70%

52-Week Range

₩1397.00 - ₩4615.00

All Time High

₩18836.30